Donald W. Glazer is Director at BeiGene, Ltd. (BGNE). They have made 9 open-market trades across 1 company since 2016, most recently 2024-06-05.
CIK 0001660940
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 9 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| BGNE | 2,718,464 | $502.1M |
Shares reported on the most recent Form 4, priced at the 2024-06-07 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BGNE | SELL | 2020-05-19 | 2020-05-21 | $169.84 | $1.7M | +4.1% | +13.0% | +44.6% |
| BGNE | SELL | 2019-05-13 | 2019-05-15 | $125.11 | $3.8M | -8.6% | -12.7% | +0.9% |
| BGNE | SELL | 2019-03-14 | 2019-03-18 | $136.10 | $4.1M | -6.5% | -10.6% | -15.8% |
| BGNE | SELL | 2018-08-29 | 2018-08-31 | $179.00 | $358K | -7.2% | -0.8% | -18.5% |
| BGNE | SELL | 2017-07-10 | 2017-07-12 | $72.14 | $1.6M | +0.7% | -2.7% | +57.2% |
| BGNE | SELL | 2016-09-28 | 2016-09-30 | $30.58 | $2.2M | +1.7% | +7.6% | -5.5% |
| BGNE | SELL | 2016-09-26 | 2016-09-28 | $29.61 | $2.8M | +6.1% | +10.6% | -2.2% |
| BGNE | SELL | 2016-09-22 | 2016-09-26 | $31.02 | $2.3M | +8.3% | +12.1% | +0.8% |
| BGNE | SELL | 2016-09-19 | 2016-09-21 | $31.41 | $4.2M | -1.2% | +5.6% | -10.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.